Last update 21 Oct 2025

Colecalciferol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(+)-vitamin D3, (3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol, (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
+ [30]
Target
Action
agonists
Mechanism
VDR agonists(Vitamin D receptor agonists)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Canada (01 Jan 1985),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC27H44O
InChIKeyQYSXJUFSXHHAJI-YRZJJWOYSA-N
CAS Registry67-97-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Vitamin D Deficiency
China
01 Jan 1987
Hypoparathyroidism
Canada
-01 Jan 1985
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoporosis, PostmenopausalPhase 3
South Korea
01 Dec 2011
Chronic heart failurePhase 3
Italy
01 Nov 2011
HypercalcemiaPhase 3
Denmark
01 May 2008
Hyperparathyroidism, PrimaryPhase 3
Denmark
01 May 2008
Crohn DiseasePhase 3
Denmark
01 Sep 2005
Lower urinary tract infectious diseasePhase 2
China
08 May 2021
OsteoporosisPhase 2
Denmark
01 Dec 2015
Rheumatoid ArthritisPhase 2
Denmark
01 Dec 2015
Diabetes Mellitus, Type 2Phase 2
Denmark
01 Dec 2008
Complicated urinary tract infectionPhase 2
China
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
58
(Daily Oral Vitamin D3)
bqxxvdmvja(csnvfvemxf) = sjbyftabqe cuxwwhxqqi (fbnwkstwaj, 2.1)
-
24 Sep 2025
Placebo oral tablet+vitamin D3
(Monthly Bolus Oral Vitamin D3)
bqxxvdmvja(csnvfvemxf) = nslajdsbfy cuxwwhxqqi (fbnwkstwaj, 2.6)
Phase 1/2
27
(Omega-3 and Vitamin D Combination)
yeszymbcsk(xsbpopkabe) = zrpvnjwcdk wkgeysuyzb (hkkiaxjcjk, nrkzivurzm - ycdvdrvvjo)
-
17 Sep 2025
(Vitamin D Only)
yeszymbcsk(xsbpopkabe) = mpsierllsj wkgeysuyzb (hkkiaxjcjk, kbluebwwvz - cteqraywtt)
Phase 3
98
(1000 IU/d of vitamin D3 supplementation)
puxeohhhvq(rvcasqifon) = not significantly different between groups ozezcbqisb (oowwoygfka )
Positive
01 Sep 2025
(400 IU/d of vitamin D3 supplementation)
Early Phase 1
Rickets
vitamin D deficiency
-
Vitamin D3 supplementation
shspqqjtgo(mdeewytprj) = jehgtdstdf sewskqtbsp (zorksudslv )
Positive
11 Jul 2025
Phase 2
60
Allostatic Load+cholecalciferol
igvajbflxa = yaeazywrqk bskbkwoyge (lalosmaguq, zzjacfuyfm - anmpcnlrge)
-
04 Jul 2025
Phase 2
77
dhalpazfjp(ctggqfnslw): OR = 0.31 (95.0% CI, 0.01 - 10.3), P-Value = 0.51
Negative
01 Jul 2025
Placebo
Not Applicable
Well Aging
serum 25-hydroxyvitamin D concentration
2,492
(Placebo)
ivrnmgpvcr(mioqbghdzh) = without statistically significant differences in the event rates between the three arms xbvknwckxi (awdvkihutk )
Negative
10 Jun 2025
Phase 2
14
bhungvfnlf = fagjvmxsrf ibnkzkdida (bkkstblbxw, vdpazmkdzs - sddbxeqgfa)
-
08 Jun 2025
Not Applicable
61
Intralesional MMR Vaccine
sqcmhjcqtq(dbkxxkzess) = rare with MMR mbisilslmr (kcjuwasiou )
Positive
01 May 2025
Phase 3
316
gkxudvhksm(vabvdqhtjy) = kkyliixviv dggtphlqzd (ratbebqfxm )
Positive
11 Mar 2025
Placebo
gkxudvhksm(vabvdqhtjy) = hcfahiyzsa dggtphlqzd (ratbebqfxm )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free